BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan C, Hu H, Shen Y, Wang Q, Mao Y, Ye B, Xiang M. PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma. Transl Oncol 2021;14:101042. [PMID: 33618069 DOI: 10.1016/j.tranon.2021.101042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Huang L, Liu X, Li L, Wang L, Wu N, Liu Z. Novel immune subtypes identification of HER2-positive breast cancer based on immunogenomic landscape. Med Oncol 2022;39:92. [PMID: 35568771 DOI: 10.1007/s12032-022-01690-3] [Reference Citation Analysis]
2 Zhang H, Liu Y, Hu D, Liu S. Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma. Front Oncol 2022;12:844666. [PMID: 35345444 DOI: 10.3389/fonc.2022.844666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Feng C, Xu Y, Liu Y, Zhu L, Wang L, Cui X, Lu J, Zhang Y, Zhou L, Chen M, Zhang Z, Li P. Gene Expression Subtyping Reveals Immune alterations:TCGA Database for Prognosis in Ovarian Serous Cystadenocarcinoma. Front Mol Biosci 2021;8:619027. [PMID: 34631788 DOI: 10.3389/fmolb.2021.619027] [Reference Citation Analysis]
4 Zhang H, Ma Y, Zhang Q, Liu R, Luo H, Wang X. A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours. BMC Med Genomics 2022;15:97. [PMID: 35473583 DOI: 10.1186/s12920-022-01239-3] [Reference Citation Analysis]